Comparing organ-at-risk doses for high-dose-rate vaginal brachytherapy between three different planning workflows

Autor: Andrew O. Wahl, J. Gruhl, Dandan Zheng, J.L. Longo, Charles A. Enke
Rok vydání: 2017
Předmět:
Zdroj: Brachytherapy. 16:373-377
ISSN: 1538-4721
DOI: 10.1016/j.brachy.2016.11.008
Popis: Purpose The aim of this study was to compare the organ-at-risk doses to the rectum and the bladder in postoperative endometrial cancer patients who receive high-dose-rate vaginal brachytherapy (HDR-VB), when using three different methods of treatment planning: ( Workflow A ) individualized treatment planning before every fraction, ( Workflow B ) individualized treatment planning for first fraction only), and ( Workflow C ) using a template plan based on applicator choice and prescription specifics without patient-specific imaging or planning (standardized template approach). Methods and Materials Alternative plans were retrospectively created using workflows B and C for 22 patients who previously received postoperative HDR-VB using a vaginal cylinder and planned using Workflow A for endometrial cancer. The rectum and bladder were contoured on the CTs used for each fraction for dose comparison between the three methods. D 50 , D 2cc , D 1cc , D 0.1cc , and V 100 of the bladder and the rectum were compared using the two-sided Wilcoxon signed-rank test. Results A total of 123 fractions were available for comparison. For Workflow A vs. Workflow B, there was no significant difference for any rectal or bladder dosimetric parameter. For Workflow A vs. Workflow C, Workflow A delivered a significantly higher median dose to the rectum than Workflow C for D 50 , D 2cc , D 1cc , and V 100 . Workflow C delivered a significantly higher dose to the bladder than Workflow A: D 2cc , D 1cc , D 0.1cc , and V 100 . However, the magnitudes of the differences were small; the dose index difference was >75 cGy for only two fractions. Conclusion Plan standardization in HDR-VB may result in considerable time and cost savings with minimal organ-at-risk dose differences.
Databáze: OpenAIRE